R&D Systems™ Recombinant Human IL-26/AK155 Dimer Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-26/AK155 Dimer Protein is derived from E. coli. The Recombinant Human IL-26/AK155 Dimer Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9NPH9.1
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 55801
• Molecular Weight (g/mol): 17.7 kDa (monomer)
• Quantity: 500 μg
• Source: E. coli-derived human IL-26/AK155 protein Lys22-Gln171,with an N-terminal Met
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after opening.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Gene Symbol: IL26
• Specific Reactivity: IL-26/AK155
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Buffer: Supplied as a 0.2 μm filtered solution in NaH2PO4, NaCl and Glycerol with BSA as a carrier protein.
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.